CRON · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
$3.38-0.9%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 5, 2026
Just reported
From Cronos Group Inc.'s results release of November 5, 2026; its quarterly report has since been filed.
Actual
$63.5M
+75% y/y
+20% q/q
Guided
—
No guide given
Actual
$0.04
-43% y/y
-56% q/q
Guided
—
No guide given
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $63.5M | $36.3M | +74.61% |
| Profit | $13.8M | $26M | -46.82% |
| Profit per share | $0.04 | $0.07 | -42.86% |
| Free Cash Flow | $24.4M | $8.8M | +176.31% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Cronos Group Inc. reported on November 5, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Cronos organically achieved records across net revenue, gross profit, and Adjusted EBITDA for the second consecutive quarter, while at the same time reducing shares outstanding. In Canada, the Spinach ® brand continued to gain significant market share, maintaining its #1 position in vapes for the third consecutive quarter and its #1 position in edibles for the ninth consecutive quarter, 1 while also making notable gains in pre-rolls and flower. Cronos Israel delivered its eleventh consecutive quarter of record net revenue, with PEACE NATURALS ® maintaining its position as the leading cannabis brand in the country. 2 Outside of Israel, our international business also delivered another record net revenue quarter, led by strong demand in Germany,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Cronos is a global cannabis company focused on scaling leading consumer goods products through R&D and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach ® , PEACE NATURALS ® , LIT ™ , Lord Jones ® and C.O.G.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Cronos Group Inc.’s Item 2.02 8-K filed November 5, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Actual
$9M
+22% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.